North Carolina – Regional Life Sciences Roundup -October 16th, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
This week, North Carolina companies weren’t asking whether the science works. They were answering what comes next: who pays for it, who leads it, and who it reaches.
Start with the money. Lenders put $237.7M behind a Novartis-anchored manufacturing campus in Morrisville, Liquidia agreed to a net $380.7M settlement to end its legal fight and keep its pulmonary arterial hypertension therapy on the market, and Labcorp has agreed to pay $722M in cash for a prostate cancer blood test and a bigger lab network.
Then came the people who made it happen. Vogenx moved a longtime board member into a new Chief Commercial Officer role as its lead drug candidate heads toward later-stage development, a sign that the conversation is shifting from clinical questions to how it will reach patients.
The talent and infrastructure behind it keep growing, too. Alamance Community College is building a new degree to train biopharma quality technicians, and RTI International will coordinate a federal network focused on emerging viral threats. North Carolina isn’t only proving the science. It’s building everything that comes after it.
Financial
Tracking the capital moving through North Carolina— funding rounds, M&A activity, and investment trends shaping NC’s life sciences companies.
Lenders Are Betting Big to the Tune of $237.7 Million on Biomanufacturing Space
Financing is in place for the first phase of Pathway Triangle, a Morrisville manufacturing campus anchored by Novartis, with Liquidia among its tenants. JLL, which arranged the loan, says lender interest reflects strong tenant demand for ready-to-use biomanufacturing space in the Research Triangle. One building is still open for lease, and a second phase is planned. Read More >
Six Lawsuits, One Agreement: A Morrisville Biotech Pays a Net $380.7M to End the Fight
Morrisville-based Liquidia has reached a global settlement with United Therapeutics that resolves all pending litigation between the two companies, with Liquidia paying a net $380.7 million in installments through 2027. Liquidia says the deal keeps its pulmonary arterial hypertension therapy, YUTREPIA, available to patients and lets it focus on growing the drug and advancing its pipeline. It says it expects to fund the payments from product sales and cash on hand. Read More >
A North Carolina Company Is Paying $722M in Cash for a Prostate Cancer Blood Test and More
Burlington-based Labcorp has agreed to acquire select assets of OPKO Health’s BioReference Health, adding clinical, women’s health, urology, and corrections testing along with a network of patient service centers. The deal also includes an FDA-approved blood test that helps predict aggressive prostate cancer before a biopsy decision. Labcorp says it will widen access to specialty testing nationwide, while OPKO says the sale lets it focus on its biopharmaceutical business. Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
From Oversight to Execution: Inside Vogenx’s Newest Leadership Move
Richard Gorman is trading his seat on the Vogenx board for a newly created Chief Commercial Officer role as the Raleigh biotech readies its lead drug candidate for later-stage development. The move shows how quickly the conversation is shifting from clinical questions to how the company will reach patients. Read More >
Erik Aune COO at Oculus Wins the Sabai and Scout Grant Program for the Society for Clinical Research Sites (SCRS) Site Solutions Summit
Oculus Research is an independent ophthalmology clinical research site in Garner, and the grant covers the conference pass, travel, and lodging that let its leadership bring industry-wide playbooks back home. The focus is on two persistent hurdles: reaching patients who rarely have access to clinical research, and growing a site without sacrificing quality. For patients in the region, the goal is continued access to emerging eye therapies. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across North Carolina’s life sciences and biotech employers.
An RTP Institute Takes the Lead on a Federal Outbreak-Readiness Network
RTI International in Research Triangle Park will lead the coordination center for NIAID’s renewed CREID Network, linking nine research centers focused on emerging viruses and outbreak readiness. The renewal comes with enhanced biosafety and federal oversight measures. It keeps an RTP institution at the center of national outbreak-readiness research. Read More >
Quality Control Meets Automation and AI in a New North Carolina Degree
Alamance Community College is creating a new associate degree in biopharma quality to train the quality control and quality assurance technicians that local industry partners say they need. Built around hands-on labs, evening hybrid courses for working adults, and training that integrates automation and AI, the program is also designed to be shared with other North Carolina colleges. Read More >
Who’s hiring?!
Top Employer
ICON is a Dublin-headquartered clinical research organization (CRO) that helps pharma, biotech, and medical device companies run clinical trials, with employees in 119 locations across 53 countries. It describes its reach as global, and it runs trial services from early-phase studies through patient-facing research sites.
In North Carolina, ICON has offices in Raleigh and Wilmington, and its Accellacare site network runs clinical research sites in the Cary and Raleigh area, where roles include research coordinators and interns who support patient visits.
They are currently hiring across 15+ roles in the North Carolina region. Apply Now >
Other employers and available roles we’re paying attention to this week:
- Amgen (Holly Springs, NC) is hiring a PD Engineer l | Apply Now >
- Merck (Durham, NC) is hiring a Specialist Business Consulting | Apply Now >
- Becton Dickinson (Durham, NC ) is hiring a Warehouse Operator | Apply Now >
- CRB (Raleigh, NC) is hiring an Automation Engineer V | Apply Now >
- Science 37 (Morrisville, NC ) is hiring a Quality Assurance Specialist | Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across North Carolina.
Early Gene Therapy Data Offer Encouraging Signs for Two Rare Eye Diseases
Opus Genetics of Research Triangle Park presented early gene therapy results for two inherited retinal diseases at Retina in Rio 2026, reporting sustained vision improvements in adults treated for one of them. The company says the interim data are guiding its next steps, including a Phase 3 trial for its LCA5 program that is expected to begin dosing later this year. Read More >
Could an Engineered Vessel Beat the Fistula for Women on Dialysis?
Durham’s Humacyte will share interim Phase 3 results at ASN Kidney Week on whether its bioengineered vessel can offer women on hemodialysis a better option than a fistula. A UNC School of Medicine physician will present the data, which Humacyte says forms the foundation for a planned label expansion. Read More >
Ecosystem
The partnerships, programs, and policy moves building North Carolina’s life sciences infrastructure — and the organizations driving it forward.
One RTP Company Aims to Speed Up Trials With New Tools
RTP-based IQVIA is expanding its partnership with Veeva Systems, standardizing several Veeva applications across its clinical development studies. The companies say the move aims to speed up trials and strengthen how research sites work with sponsors, while customers keep the flexibility to choose other technologies. Read More >
Patents, PBMs, and Pricing: What the Congresswoman Told NCLifeSci’s Annual Dinner
U.S. Rep. Deborah Ross urged North Carolina life sciences leaders to tell their stories to elected officials as federal research cuts, grant delays, and regulatory uncertainty weigh on the industry. Speaking at the NCLifeSci Annual Dinner, she weighed in on patents, drug pricing, and the need for bipartisan deals after the November elections. Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in NC biotech and life sciences this week.
New Novel Explores the Miracle of Research Triangle Park
Written by Mack Paul and his late father, Allen Paul, Miracle Road is a new book from Duke University Press on how Research Triangle Park came to be, and it argues the region’s success was never guaranteed. In this Axios Q&A, Mack Paul credits long-term collaboration among universities, businesses, and government, and looks ahead to mixed-use innovation hubs and the lasting role of lab-ready office parks. Read More >
Why a Postharvest Sweetpotato Problem Is Getting Research Funding
North Carolina is receiving USDA Specialty Crop Block Grant funding for research, marketing, and innovation, including NC State University work on sour rot in sweet potatoes, a crop the state leads the nation in producing. The North Carolina Sweetpotato Commission says the research targets a clear industry need for tools that reduce postharvest losses. Read More >
Could Climate Change Help Pathogens Jump Into Humans?
Duke biologist Amy Gladfelter says fungi are everywhere yet mostly overlooked, and that a changing climate may be helping some of them become threats to human health. Her lab studies the unusual cell structures that let fungi adapt, and she has found surprising parallels with the placenta and with some treatment-resistant cancers. It’s part of a Duke series on fungal research. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across North Carolina’s life sciences ecosystem that you don’t want to miss.
NC LifeSci Legislative Luncheon & Forum
Monday, October 19, 2026 • 11:30 AM – 2 PM • NC Biotechnology Center in Durham, NC
Hosted by NC LifeSci| Register Now >
Bridging the Gap by NCABR
October 22-23, 2026 • 8 AM – 4 PM • North Carolina
Hosted by NCABR| Register Now >
NC LifeSci Contract R & D Luncheon & Forum: The Path to Success- Concept to Commercialization
Thursday, October 29, 2026 • 11:30 AM – 2 PM • NC Biotechnology Center in Durham, NC
Hosted by NC LifeSci| Register Now >
Did we miss something!? Drop us a line →
Stay connected to North Carolina’s Region life sciences.
🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →
Get the North Carolina Region Roundup every Friday.
The week’s most important life sciences news from the NC region— delivered to your inbox.
